A dose-block randomized, double-blind, placebo-controlled, single dosing, dose-escalation phase I clinical trial to investigate the safety/tolerability and pharmacokinetics of HNP-2006 after intravenous administration in healthy adult volunteers
Latest Information Update: 02 May 2023
At a glance
- Drugs HNP 2006 (Primary)
- Indications CNS cancer
- Focus Pharmacokinetics
- Sponsors Hana Pharm
Most Recent Events
- 24 Mar 2023 Results assessing safety, tolerability, and pharmacokinetics (PKs) of HNP-2006 after a single intravenous (IV) administration in healthy subjects, presented at the 124th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 01 Dec 2020 New trial record